We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
-0.09%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$42.9B
AUM Growth
-$1.96B
(-4.4%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
17.86%
Holding
1,839
New
489
Increased
526
Reduced
486
Closed
315
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$642M |
| 2 |
Lam Research
LRCX
|
+$177M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$176M |
| 4 |
Cisco
CSCO
|
+$176M |
| 5 |
Starbucks
SBUX
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$420M |
| 2 |
Boeing
BA
|
+$406M |
| 3 |
IBM
IBM
|
+$347M |
| 4 |
Oracle
ORCL
|
+$318M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.1% |
| 2 | Technology | 19.47% |
| 3 | Consumer Discretionary | 17.17% |
| 4 | Healthcare | 13.69% |
| 5 | Industrials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSLR
1176
Neostellar Capital Corp
NSLR
$254M
| $961K | ﹤0.01% |
183,415
+2,170
| +1% | +$11.7K |
|
1177
Ionis Pharmaceuticals
IONS
$9.4B
| $959K | ﹤0.01% |
+16,000
| New | +$1.04M |
|
1178
Wintrust Financial
WTFC
$10.7B
| $957K | ﹤0.01% |
14,800
-40,200
| -73% | -$2.67M |
|
1179
Canadian Solar
CSIQ
$1.08B
| $954K | ﹤0.01% |
50,556
-74,344
| -60% | -$1.62M |
|
1180
Westwood Holdings Group
WHG
$190M
| $954K | ﹤0.01% |
34,495
+4,400
| +15% | +$134K |
|
1181
Kimberly-Clark
KMB
$36.5B
| $952K | ﹤0.01% |
+6,700
| New | +$921K |
|
1182
NACCO Industries
NC
$320M
| $949K | ﹤0.01% |
14,849
-4,754
| -24% | -$248K |
|
|
GLDD
1183
DELISTED
Great Lakes Dredge & Dock
GLDD
| $942K | ﹤0.01% |
90,133
+77,361
| +606% | +$818K |
|
|
SAFE
1184
Safehold
SAFE
$1.15B
| $942K | ﹤0.01% |
+14,828
| New | +$931K |
|
1185
Coda Octopus Group
CODA
$120M
| $941K | ﹤0.01% |
114,641
+42,110
| +58% | +$457K |
|
1186
American Superconductor
AMSC
$1.59B
| $922K | ﹤0.01% |
117,568
-117,433
| -50% | -$998K |
|
1187
J. Jill
JILL
$283M
| $922K | ﹤0.01% |
97,042
+43,958
| +83% | +$447K |
|
1188
Tejon Ranch
TRC
$451M
| $915K | ﹤0.01% |
+53,900
| New | +$939K |
|
1189
Goosehead Insurance
GSHD
$2.32B
| $913K | ﹤0.01% |
+18,500
| New | +$850K |
|
|
BCIC
1190
BCP Investment Corp
BCIC
$92.9M
| $907K | ﹤0.01% |
40,295
-1,579
| -4% | -$36.8K |
|
1191
Southern Company
SO
$107B
| $902K | ﹤0.01% |
+14,600
| New | +$846K |
|
1192
Mercantile Bank Corp
MBWM
$1.05B
| $896K | ﹤0.01% |
27,324
+17,757
| +186% | +$571K |
|
|
UBA
1193
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $875K | ﹤0.01% |
+36,901
| New | +$806K |
|
1194
Riverview Bancorp
RVSB
$108M
| $871K | ﹤0.01% |
118,028
+12,534
| +12% | +$97.3K |
|
|
GLOG
1195
DELISTED
GASLOG LTD
GLOG
| $870K | ﹤0.01% |
67,722
+448
| +0.7% | +$6K |
|
1196
CME Group
CME
$94.8B
| $866K | ﹤0.01% |
+4,100
| New | +$857K |
|
|
REVG
1197
DELISTED
REV Group
REVG
| $864K | ﹤0.01% |
+75,600
| New | +$937K |
|
|
PDLI
1198
DELISTED
PDL BioPharma, Inc.
PDLI
| $862K | ﹤0.01% |
398,950
-1,426,431
| -78% | -$3.81M |
|
|
CBPX
1199
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $860K | ﹤0.01% |
31,512
-236,615
| -88% | -$5.96M |
|
|
BSTC
1200
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $859K | ﹤0.01% |
16,042
-6,019
| -27% | -$350K |
|
Similar funds
VGA
Arrowstreet Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Arrowstreet Capital held 1,839 positions worth $42.9B, down 4.4% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.55B in Q3 2019, closing 315 positions and reducing 486 holdings. Its most notable exit was Salesforce, an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Lam Research worth $194M.
- Arrowstreet Capital's largest Q3 2019 buy was Lam Research: 8,415,070 shares worth $194M.
- Arrowstreet Capital added most to Microsoft in Q3 2019, an estimated $642M increase.
- Arrowstreet Capital's biggest Q3 2019 reduction was UnitedHealth, cutting an estimated $420M.
- Arrowstreet Capital fully exited Salesforce in Q3 2019, selling an estimated $219M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $42.9B portfolio in Q3 2019.
- Arrowstreet Capital opened 489 new positions and closed 315 in Q3 2019.
- Arrowstreet Capital's portfolio value fell 4.4% quarter-over-quarter to $42.9B.
Based on Arrowstreet Capital's 13F filing for Q3 2019, filed 14 Nov 2019.